$1.93
N/A
At close: Jul 14, 5:00 PM EST
$1.94
0.010.52%
After Hours: 5:33 PM EST
Aldeyra Therapeutics Inc Earnings Estimates
ALDXNASDAQ
Aldeyra Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ALDX
Aldeyra Therapeutics (ALDX) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.09 and quarterly revenue of $47.00M.
In the most recent quarter (Q1), Aldeyra Therapeutics reported EPS of $-0.06, beating estimates of $-0.12 by 0.50%. Revenue came in at $0, missing the estimate of $47.00M by 1.00%.
Aldeyra Therapeutics has beaten EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, Aldeyra Therapeutics has averaged an EPS surprise of 0.24% and a revenue surprise of 1.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$47.00M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Aldeyra Therapeutics Earnings History
Analyze the earnings history of Aldeyra Therapeutics using advanced sorting and filters.
Loading calendar...
Aldeyra Therapeutics (ALDX) Earnings Per Share
The chart below shows Aldeyra Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Aldeyra Therapeutics (ALDX) Revenue
The chart below shows Aldeyra Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?
Aldeyra Therapeutics (ALDX) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Aldeyra Therapeutics (NASDAQ:ALDX)?
The Actual EPS was $-0.06, which beat the estimate of $-0.12.
What were Aldeyra Therapeutics’s (NASDAQ:ALDX) revenues?
The Actual Revenue was $0, which missed the estimate of $47.00M.
